134 related articles for article (PubMed ID: 35681695)
1. SAR131675, a VEGRF3 Inhibitor, Modulates the Immune Response and Reduces the Growth of Colorectal Cancer Liver Metastasis.
Walsh KA; Kastrappis G; Fifis T; Paolini R; Christophi C; Perini MV
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681695
[TBL] [Abstract][Full Text] [Related]
2. Specific Inhibition of the VEGFR-3 Tyrosine Kinase by SAR131675 Reduces Peripheral and Tumor Associated Immunosuppressive Myeloid Cells.
Espagnolle N; Barron P; Mandron M; Blanc I; Bonnin J; Agnel M; Kerbelec E; Herault JP; Savi P; Bono F; Alam A
Cancers (Basel); 2014 Feb; 6(1):472-90. PubMed ID: 24589997
[TBL] [Abstract][Full Text] [Related]
3. SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.
Alam A; Blanc I; Gueguen-Dorbes G; Duclos O; Bonnin J; Barron P; Laplace MC; Morin G; Gaujarengues F; Dol F; Hérault JP; Schaeffer P; Savi P; Bono F
Mol Cancer Ther; 2012 Aug; 11(8):1637-49. PubMed ID: 22584122
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of renin-angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases.
Vallejo Ardila DL; Walsh KA; Fifis T; Paolini R; Kastrappis G; Christophi C; Perini MV
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32448803
[TBL] [Abstract][Full Text] [Related]
5. DC101, an anti-VEGFR2 agent, promotes high-endothelial venule formation and immune infiltration versus SAR131675 and fruquintinib.
Wang Z; Shi X; Zhao Y; Zhou J; Zhang S; Wang J; Yu W; Zhang X; Ren X; Zhao H
Biochem Biophys Res Commun; 2023 Jun; 661():10-20. PubMed ID: 37084488
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db/db mice.
Hwang SD; Song JH; Kim Y; Lim JH; Kim MY; Kim EN; Hong YA; Chung S; Choi BS; Kim YS; Park CW
Cell Death Dis; 2019 Mar; 10(3):219. PubMed ID: 30833548
[TBL] [Abstract][Full Text] [Related]
7. Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade.
Tachinami H; Nishii N; Xia Y; Kashima Y; Ohno T; Nagai S; Li L; Lau W; Tomihara K; Noguchi M; Azuma M
Oral Oncol; 2019 Apr; 91():21-28. PubMed ID: 30926058
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
9. SAR131675 Receptor Tyrosine Kinase Inhibitor Induces Apoptosis through Bcl- 2/Bax/Cyto c Mitochondrial Pathway in Human Umbilical Vein Endothelial Cells.
Babaei Z; Panjehpour M; Parsian H; Aghaei M
Anticancer Agents Med Chem; 2022; 22(5):943-950. PubMed ID: 34238175
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice.
Ma X; Zhou Z; Zhang X; Fan M; Hong Y; Feng Y; Dong Q; Diao H; Wang G
Cell Biol Toxicol; 2020 Oct; 36(5):509-515. PubMed ID: 32172331
[TBL] [Abstract][Full Text] [Related]
11. Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.
Du Four S; Maenhout SK; De Pierre K; Renmans D; Niclou SP; Thielemans K; Neyns B; Aerts JL
Oncoimmunology; 2015 Apr; 4(4):e998107. PubMed ID: 26137411
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor-1α inhibition augments efficacy of programmed cell death 1 antibody in murine prostatic cancer models.
Shen Z; Pei Q; Zhang H; Yang C; Cui H; Li B; Liu J; Bo Z; Wei F; Zhang M; Liu C
Anticancer Drugs; 2022 Jul; 33(6):587-594. PubMed ID: 35324523
[TBL] [Abstract][Full Text] [Related]
13. MGP promotes CD8
Rong D; Sun G; Zheng Z; Liu L; Chen X; Wu F; Gu Y; Dai Y; Zhong W; Hao X; Zhang C; Pan X; Tang J; Tang W; Wang X
Int J Biol Sci; 2022; 18(6):2345-2361. PubMed ID: 35414780
[TBL] [Abstract][Full Text] [Related]
14. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
16. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
17. Endogenous Uteroglobin as Intrinsic Anti-inflammatory Signal Modulates Monocyte and Macrophage Subsets Distribution Upon Sepsis Induced Lung Injury.
Janicova A; Becker N; Xu B; Wutzler S; Vollrath JT; Hildebrand F; Ehnert S; Marzi I; Störmann P; Relja B
Front Immunol; 2019; 10():2276. PubMed ID: 31632392
[TBL] [Abstract][Full Text] [Related]
18. Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer.
Zhou G; Noordam L; Sprengers D; Doukas M; Boor PPC; van Beek AA; Erkens R; Mancham S; Grünhagen D; Menon AG; Lange JF; Burger PJWA; Brandt A; Galjart B; Verhoef C; Kwekkeboom J; Bruno MJ
Oncoimmunology; 2018; 7(7):e1448332. PubMed ID: 29900067
[No Abstract] [Full Text] [Related]
19. Metabolomic profiling of tumor-infiltrating macrophages during tumor growth.
Umemura N; Sugimoto M; Kitoh Y; Saio M; Sakagami H
Cancer Immunol Immunother; 2020 Nov; 69(11):2357-2369. PubMed ID: 32518979
[TBL] [Abstract][Full Text] [Related]
20. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
